Page last updated: 2024-11-07

prednisone and Cutaneous Phaeohyphomycosis

prednisone has been researched along with Cutaneous Phaeohyphomycosis in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Truffaut, S1
Bigaillon, C1
Leroy, P1
Bialé, L1
Glanowski, C1
Imbert, I1
Lechevalier, D1
Banal, F1
Liu, AW1
Bateman, AC1
Greenbaum, A1
Garvin, K1
Clarridge, J1
Grim, J1

Other Studies

2 other studies available for prednisone and Cutaneous Phaeohyphomycosis

ArticleYear
Phaeohyphomycotic tenosynovitis after local steroid injection during methotrexate therapy for rheumatoid arthritis: A case-report.
    Joint bone spine, 2017, Volume: 84, Issue:6

    Topics: Arthritis, Rheumatoid; Combined Modality Therapy; Drainage; Follow-Up Studies; Humans; Immunocomprom

2017
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3

    Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal

2017